
De Novo Foodlabs makes nature-identical, precision-fermented protein ingredients to help food and nutrition companies offer healthier, more sustainable products. The company uses a proprietary biotech platform that combines precision fermentation with machine-learning–driven biopharma discovery models and Python-based workflows to design and optimize protein-based nutrients. Its R&D employs analytical techniques such as SPR and other experimental tools to validate functionality and scale production. De Novo commercializes ingredients through product development, licensing, and partnerships with Food & Beverage and nutrition firms.

De Novo Foodlabs makes nature-identical, precision-fermented protein ingredients to help food and nutrition companies offer healthier, more sustainable products. The company uses a proprietary biotech platform that combines precision fermentation with machine-learning–driven biopharma discovery models and Python-based workflows to design and optimize protein-based nutrients. Its R&D employs analytical techniques such as SPR and other experimental tools to validate functionality and scale production. De Novo commercializes ingredients through product development, licensing, and partnerships with Food & Beverage and nutrition firms.
What they do: Precision-fermented, nature-identical protein ingredients (example: NanoFerrin™ lactoferrin analogue)
HQ: Raleigh, North Carolina, USA
Founded: 2021
Team size: Approximately 11 employees
Recent funding: Seed round announced Aug 19, 2024
Sustainable and functional nutritional ingredients for food, beverage and nutrition markets
2021
Biotechnology
Seed round announced Aug 19, 2024 (per funding summary)
“Multiple early-stage investors and partners including Joyful Ventures, Sustainable Food Ventures, Big Idea Ventures, Cult Food Science, Global Agri-Food Advancement Partnership, Pascual Innoventures, UM6P Ventures and others (logos/credits shown on company site and listed in profiles).”